Literature DB >> 19959667

Ca2+ dysregulation in Ryr1(I4895T/wt) mice causes congenital myopathy with progressive formation of minicores, cores, and nemaline rods.

Elena Zvaritch1, Natasha Kraeva, Eric Bombardier, Robert A McCloy, Frederic Depreux, Douglas Holmyard, Alexander Kraev, Christine E Seidman, J G Seidman, A Russell Tupling, David H MacLennan.   

Abstract

Ryr1(I4895T/wt) (IT/+) mice express a knockin mutation corresponding to the human I4898T EC-uncoupling mutation in the type 1 ryanodine receptor/Ca(2+) release channel (RyR1), which causes a severe form of central core disease (CCD). IT/+ mice exhibit a slowly progressive congenital myopathy, with neonatal respiratory stress, skeletal muscle weakness, impaired mobility, dorsal kyphosis, and hind limb paralysis. Lesions observed in myofibers from diseased mice undergo age-dependent transformation from minicores to cores and nemaline rods. Early ultrastructural abnormalities include sarcomeric misalignment, Z-line streaming, focal loss of cross-striations, and myofibrillar splitting and intermingling that may arise from defective myofibrillogenesis. However, manifestation of the disease phenotype is highly variable on a Sv129 genomic background. Quantitative RT-PCR shows an equimolar ratio of WT and mutant Ryr1 transcripts within IT/+ myofibers and total RyR1 protein expression levels are normal. We propose a unifying theory in which the cause of core formation lies in functional heterogeneity among RyR1 tetramers. Random combinations of normal and either leaky or EC-uncoupled RyR subunits would lead to spatial differences in Ca(2+) transients; the resulting heterogeneity of contraction among myofibrils would lead to focal, irreversible tearing and shearing, which would, over time, enlarge to form minicores, cores, and nemaline rods. The IT/+ mouse line is proposed to be a valid model of RyR1-related congenital myopathy, offering high potential for elucidation of the pathogenesis of skeletal muscle disorders arising from impaired EC coupling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19959667      PMCID: PMC2788482          DOI: 10.1073/pnas.0912126106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  The spectrum of pathology in central core disease.

Authors:  C A Sewry; C Müller; M Davis; J S M Dwyer; J Dove; G Evans; R Schröder; D Fürst; T Helliwell; N Laing; R C M Quinlivan
Journal:  Neuromuscul Disord       Date:  2002-12       Impact factor: 4.296

2.  Minicore myopathy in children: a clinical and histopathological study of 19 cases.

Authors:  H Jungbluth; C Sewry; S C Brown; A Y Manzur; E Mercuri; K Bushby; P Rowe; M A Johnson; I Hughes; A Kelsey; V Dubowitz; F Muntoni
Journal:  Neuromuscul Disord       Date:  2000-06       Impact factor: 4.296

Review 3.  Neurogenesis of excitation-contraction uncoupling in aging skeletal muscle.

Authors:  Anthony Michael Payne; Osvaldo Delbono
Journal:  Exerc Sport Sci Rev       Date:  2004-01       Impact factor: 6.230

Review 4.  Dynamic properties of mammalian skeletal muscles.

Authors:  R I Close
Journal:  Physiol Rev       Date:  1972-01       Impact factor: 37.312

5.  Central core disease or not? Observations on a family with a non-progressive myopathy.

Authors:  J A Morgan-Hughes; E M Brett; B D Lake; F M Tomé
Journal:  Brain       Date:  1973-09       Impact factor: 13.501

6.  Central core disease of muscle: clinical, histochemical and electron microscopic studies of an affected mother and child.

Authors:  V Dubowitz; S Roy
Journal:  Brain       Date:  1970       Impact factor: 13.501

7.  An electron microscope study of fibre types in normal and dystrophic muscles of the mouse.

Authors:  S A Shafiq; M A Gorycki; A T Milhorat
Journal:  J Anat       Date:  1969-03       Impact factor: 2.610

8.  The relationship between target, targetoid, and targetoid/core fibers in severe neurogenic muscular atrophy.

Authors:  H P Schmitt; B Volk
Journal:  J Neurol       Date:  1975-09-22       Impact factor: 4.849

9.  A homozygous splicing mutation causing a depletion of skeletal muscle RYR1 is associated with multi-minicore disease congenital myopathy with ophthalmoplegia.

Authors:  Nicole Monnier; Ana Ferreiro; Isabelle Marty; Annick Labarre-Vila; Paulette Mezin; Joel Lunardi
Journal:  Hum Mol Genet       Date:  2003-05-15       Impact factor: 6.150

10.  Common origin of rods, cores, miniature cores, and focal loss of cross-striations.

Authors:  J Bethlem; W F Arts; K P Dingemans
Journal:  Arch Neurol       Date:  1978-09
View more
  36 in total

Review 1.  Special article: Future directions in malignant hyperthermia research and patient care.

Authors:  Sharon J Hirshey Dirksen; Marilyn Green Larach; Henry Rosenberg; Barbara W Brandom; Jerome Parness; Robert Scott Lang; Meera Gangadharan; Tyler Pezalski
Journal:  Anesth Analg       Date:  2011-06-27       Impact factor: 5.108

2.  Type 1 ryanodine receptor knock-in mutation causing central core disease of skeletal muscle also displays a neuronal phenotype.

Authors:  Valerie De Crescenzo; Kevin E Fogarty; Jason J Lefkowitz; Karl D Bellve; Elena Zvaritch; David H MacLennan; John V Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-27       Impact factor: 11.205

Review 3.  Congenital myopathies: an update.

Authors:  Jessica R Nance; James J Dowling; Elizabeth M Gibbs; Carsten G Bönnemann
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

4.  Mice expressing T4826I-RYR1 are viable but exhibit sex- and genotype-dependent susceptibility to malignant hyperthermia and muscle damage.

Authors:  Benjamin Yuen; Simona Boncompagni; Wei Feng; Tianzhong Yang; Jose R Lopez; Klaus I Matthaei; Samuel R Goth; Feliciano Protasi; Clara Franzini-Armstrong; Paul D Allen; Isaac N Pessah
Journal:  FASEB J       Date:  2011-11-30       Impact factor: 5.191

5.  Defects in Ca2+ release associated with local expression of pathological ryanodine receptors in mouse muscle fibres.

Authors:  Romain Lefebvre; Claude Legrand; Estela González-Rodríguez; Linda Groom; Robert T Dirksen; Vincent Jacquemond
Journal:  J Physiol       Date:  2011-10-03       Impact factor: 5.182

Review 6.  Ryanodine receptor channelopathies.

Authors:  Matthew J Betzenhauser; Andrew R Marks
Journal:  Pflugers Arch       Date:  2010-02-24       Impact factor: 3.657

Review 7.  Physiology and pathophysiology of excitation-contraction coupling: the functional role of ryanodine receptor.

Authors:  Gaetano Santulli; Daniel R Lewis; Andrew R Marks
Journal:  J Muscle Res Cell Motil       Date:  2017-06-26       Impact factor: 2.698

Review 8.  Pathophysiological concepts in the congenital myopathies: blurring the boundaries, sharpening the focus.

Authors:  Gianina Ravenscroft; Nigel G Laing; Carsten G Bönnemann
Journal:  Brain       Date:  2014-12-31       Impact factor: 13.501

Review 9.  Malignant Hyperthermia in the Post-Genomics Era: New Perspectives on an Old Concept.

Authors:  Sheila Riazi; Natalia Kraeva; Philip M Hopkins
Journal:  Anesthesiology       Date:  2018-01       Impact factor: 7.892

10.  SPEG interacts with myotubularin, and its deficiency causes centronuclear myopathy with dilated cardiomyopathy.

Authors:  Pankaj B Agrawal; Christopher R Pierson; Mugdha Joshi; Xiaoli Liu; Gianina Ravenscroft; Behzad Moghadaszadeh; Tiffany Talabere; Marissa Viola; Lindsay C Swanson; Göknur Haliloğlu; Beril Talim; Kyle S Yau; Richard J N Allcock; Nigel G Laing; Mark A Perrella; Alan H Beggs
Journal:  Am J Hum Genet       Date:  2014-07-31       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.